GPT and Hepatic fibrosis: The frequent elevations in serum ALT observed during exposure to deferiprone in these patients are consistent with our previous observations of hepatic dysfunction arising and hepatic fibrosis progressing during deferiprone therapy, even in patients whose body iron had stabilized [23, 24].